Cellular and Molecular Mechanisms of Drug Dependence
The DOI matches its Crossref record; 188 of the 189 references it cites were found in a registry or an index.
Abstract
The molecular and cellular actions of three classes of abused drugs—opiates, psychostimulants, and ethanol—are reviewed in the context of behavioral studies of drug dependence. The immediate effects of drugs are compared to those observed after long-term exposure. A neurobiological basis for drug dependence is proposed from the linkage between the cellular and behavioral effects of these drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The emotional dysregulation that is associated with the withdrawal/negative affect stage also involves a between-system neuroadaptation, in which neuro-chemical systems other than those involved in the positive rewarding effects of drugs of abuse are recruited or dysregulated by chronic activation of the reward system.”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [68]
In the citing paper
“A key theory that was proposed was called opponent process theory (Solomon andCorbit, 1973, 1974;D'Amato, 1974;Hoffman and Solomon, 1974;Solomon, 1980;Koob and Bloom, 1988).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“A conceptual framework that was adopted to explain the neural systems that mediate the long-hypothesized opponent process adaptation to excessive reward system engagement and drive negative reinforcement involved the within-system downregulation of brain reward circuitry and the between-system recruitment of brain stress circuitry (Koob and Bloom, 1988).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“Subsequently, the focus of between-system neuroadaptations fell on understanding neurocircuitry within the extended amygdala and its role in opponent process, more specifically hyperkatifeia (Koob and Bloom, 1988;Koob and Le Moal, 2008;Koob, 2019).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
In the citing paper
“In addition to the above within-system neuroadaptations, other neurocircuits appear to be activated by excessive drug intake that act in hedonic opposition to reward neurotransmitter circuits [corticotropinreleasing factor (CRF), norepinephrine, glucocorticoids, dynorphin, hypocretin, and neuroimmune factors] or act to protect against the development of hyperkatifeia (NPY, nociceptin, endocannabin”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Koob and Bloom, 1988
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Siegel, L. J., & Fletcher‐Janzem, E. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0655 · Cited by 8,477
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Positron emission tomographic studies of the cortical anatomy of single-word processing
Petersen, S. E., Fox, P. T., Posner, M. I., Mintun, M., & Raichle, M. E. (1988) · Nature · doi:10.1038/331585a0 · Cited by 2,593
Neurogenetic Adaptive Mechanisms in Alcoholism
Cloninger, C. R. (1987) · Science · doi:10.1126/science.2882604 · Cited by 2,234
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960
Self-citationNucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Self-citationLocalization of Cognitive Operations in the Human Brain
Posner, M. I., Petersen, S. E., Fox, P. T., & Raichle, M. E. (1988) · Science · doi:10.1126/science.3289116 · Cited by 1,429
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,151
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00887.1981 · Cited by 1,068
Self-citation
Research works printed but not linked: 46
- AMERICAN JOURNAL OF PSYCHIATRY 142 7: 9 (1985).
- AMIT, Z, ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE 23: 65 (1977).
- BAXTER, L. R., JOURNAL OF CLINICAL PSYCHIATRY 49: 23 (1988).
- Bjorklund, A., Handbook of Chemical Neuroanatomy 2: 55 (1984).
- Bloom, F. E., Catecholamines, Neuropharmacology, and Central Nervous System: 159 (1984).
- BRITTON, K.T., REGUL PEPT 16: 315 (1987).
- DACKIS, C.A., BROMOCRIPTINE AS TREATMENT OF COCAINE ABUSE, LANCET 1: 1151 (1985).
- DUGGAN, A. W., PHARMACOLOGICAL REVIEWS 35: 219 (1982).
- EDDY, N.B., BULLETIN OF THE WORLD HEALTH ORGANIZATION 32: 723 (1965).
- FREDERICKSON, RCA, LIFE SCI 24: 541 (1975).
- GRIFFITHS, R.R., ADV SUBSTANC ABUSE 1: 1 (1980).
- HARDING, W.M., ADV SUBSTANC ABUSE 3: 27 (1983).
- HENRIKSEN, S.J., NATL I DRUG ABUSE RE 84: 239 (1984).
- HIMMELSBACH, C.K., FEDERATION PROCEEDINGS 2: 201 (1943).
- HUBNER, C.B., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 1717 (1987).
- JAFFE, J.H., GOODMAN GILMANS PHAR: 532 (1985).
- JAFFE, J.H., RESEARCH PUBLICATIONS. ASSOCIATION FOR RESEARCH IN NERVOUS AND MENTAL DISEASE 46: 226 (1968).
- Khachaturian, H., Handbook of Chemical Neuroanatomy 4: 216 (1985).
- KOOB, G.F., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 918 (1987).
- KORNETSKY, C, AN ANIMAL-MODEL FOR OPIATE INDUCED EUPHORIA AND ANALGESIA, THERAPEUTISCHE UMSCHAU 39: 617 (1982).
- KRITIKOS, P.G., UN B NARC 19: 187 (1967).
- Kuhar, M. H., Nature 245:447 (1976).
- LACEY, M.G., INT NARCOTICS RES C: 85 (1988).
- LESLIE, F.M., PHARMACOL REV 39: 198 (1987).
- LI, T.K., NIDA RES MONOGR 66: 41 (1986).
- MADAMBA, S, SOCIETY FOR NEUROSCIENCE. ABSTRACTS 13: 501 (1987).
- Markou A. Soc. Neurosci. Abstr. in press.
- MARTIN, W.R., HDB EXPT PHARMACOLOG 45: 43 (1977).
- MARTIN, W.R., PHARMACOL REV 35: 283 (1984).
- MARTIN, W.R., PHARMACOL REV 35: 285 (1984).
- Merchenthaler, I., Handbook of Chemical Neuroanatomy 3: 273 (1985).
- MURPHY, J.M., ALCOHOL DRUG RES 7: 33 (1986).
- NADEL, L, ESSAYS NERVOUS SYSTE: 367 (1974).
- OBRIEN, C.P., ANN NY ACAD SCI 398: 377 (1983).
- OBRIEN, C.P., PHARMACOL REV 27: 533 (1976).
- PICKENS, R, HDB PSYCHOPHARMACOLO 12: 1 (1978).
- SAMSON, H.H., NEUROBEHAVIORAL PHAR: 221 (1987).
- SHUSTER, L, NIDA RES MONOGR 54: 50 (1984).
- TABAKOFF, B, ANIMAL MODELS ALCOHO: 271 (1980).
- VACCARINO, F.J., EFFECTS OF INTRACEREBROVENTRICULAR ADMINISTRATION OF METHYL NALOXONIUM CHLORIDE ON HEROIN SELF-ADMINISTRATION IN THE RAT, PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 23: 495 (1985).
- WALMSLEY, J, PHARMACOL REV 35: 69 (1983).
- WAY, E.L., ANN NY ACAD SCI 398: 12 (1983).
- WHITE, F.J., NEUROPHARMACOLOGY DO: 67 (1987).
- WIKLER, A, NARCOTICS: 85 (1965).
- WILSON, JVR, BEHAV GENET 11: 291 (1984).
- WOODS, J.H., RECENT ADV STUDIES A: 413 (1970).
Cited by
Items 401–500 of 1,010
MK‐801 prevents the development of behavioral sensitization during repeated morphine administration
Jeziorski, M., White, F. J., & Wolf, M. E. (1994) · Synapse · doi:10.1002/syn.890160207 · Cited by 133
Cunningham, S. T., & Kelley, A. E. (1992) · Brain Research · doi:10.1016/0006-8993(92)91349-j · Cited by 137
VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation
Grieder, T. E., Herman, M. A., Contet, C., Tan, L. A., Vargas-Perez, H., Cohen, A., Chwalek, M., Maal-Bared, G., Freiling, J., Schlosburg, J. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3872 · Cited by 132
Self-citationLamont, E. W., & Kokkinidis, L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00281-9 · Cited by 152
Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum
White, N. M., & Hiroi, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6486 · Cited by 132
Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal
Diana, M., Muntoni, A. L., Pistis, M., Melis, M., & Gessa, G. L. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00488.x · Cited by 131
Efficacy of Psychostimulant Drugs for Cocaine Dependence
Castells, X., Casas, M., Pérez-Mañá, C., Roncero, C., Vidal, X., & Capellà, D. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007380.pub3 · Cited by 130
Beitner-Johnson, D., Guitart, X., & Nestler, E. J. (1991) · Brain Research · doi:10.1016/0006-8993(91)90759-o · Cited by 131
Wu, Q., Reith, M. E. A., Kuhar, M. J., Carroll, F. I., & Garris, P. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06338.2001 · Cited by 130
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans
Bisaga, A. M., Comer, S. D., Ward, A. S., Popik, P., Kleber, H. D., & Fischman, M. W. (2001) · Psychopharmacology · doi:10.1007/s002130100739 · Cited by 145
Epping-Jordan, M. P., Markou, A., & Koob, G. F. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01190-6 · Cited by 144
Self-citationPathological overeating: emerging evidence for a compulsivity construct
Moore, C. F., Sabino, V., Koob, G. F., & Cottone, P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.269 · Cited by 126
“The neurobiological substrates that underlie this element of compulsivity are dual: within-system neuroadaptations, which refer to the downregulation of reward neurotransmission (Koob and Bloom, 1988), and between-system neuroadaptations, which refer to the recruitment of the brain ‘antireward’ stress systems during f…”
Self-citationQi, J., Yang, J.-Y., Song, M., Li, Y., Wang, F., & Wu, C.-F. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0245-8 · Cited by 129
“The notion that the mesolimbic dopamine (DA) system that originates in the ventral tegmental area plays an essential role in the reinforcing actions of many drugs of abuse (including MAP) is not new (Fibiger 1978; Wise 1978; Koob and Bloom 1988; Nestler et al. 1996; Pierce and Kalivas 1997).”
BackgroundRoy, A., & Pandey, S. C. (2002) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-200206000-00008 · Cited by 129
Diana, M., Pistis, M., Muntoni, A. L., & GESSA, G. L. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00482-3 · Cited by 139
Basso, A. M., & Kelley, A. E. (1999) · Behavioral Neuroscience · doi:10.1037//0735-7044.113.2.324 · Cited by 129
Tomkins, D. M., & Sellers, E. M. (2001) · Europe PMC (PubMed Central) · Cited by 178
Dopamine-dependent responses to morphine depend on glucocorticoid receptors
Marinelli, M., Aouizerate, B., Barrot, M., Le Moal, M., & Piazza, P. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7742 · Cited by 128
The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder
Chye, Y., Christensen, E., Solowij, N., & Yücel, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00063 · Cited by 126
Nitric oxide and substance dependence
Uzbay, T. I., & Oglesby, M. W. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00049-x · Cited by 140
Melia, K. R., Ryabinin, A. E., Corodimas, K. P., Wilson, M. C., & LeDoux, J. E. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00138-8 · Cited by 127
Drug Policy: Striking the Right Balance
Goldstein, A., & Kalant, H. (1990) · Science · doi:10.1126/science.2218493 · Cited by 126
Actions of cocaine on rat dopaminergic neurones in vitro
Lacey, M. G., Mercuri, N. B., & North, R. A. (1990) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1990.tb12998.x · Cited by 127
Study of the addictive potential of modafinil in naive and cocaine-experienced rats
Deroche‐Gamonet, V., Darnaudéry, M., Bruins-Slot, L., Piat, F., Moal, M. L., & Piazza, P. V. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1080-8 · Cited by 133
Neuropharmacology of Cocaine and Ethanol Dependence
Koob, G. F., & Weiss, F. (1992) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1648-8_11 · Cited by 138
Self-citationBockstaele, E. J. V., Cestari, D. M., & Pickel, V. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91330-7 · Cited by 148
Nicotine response genetics in the zebrafish
Petzold, A. M., Balciunas, D., Sivasubbu, S., Clark, K. J., Bedell, V. M., Westcot, S. E., Myers, S. R., Moulder, G. L., Thomas, M. J., & Ekker, S. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908247106 · Cited by 140
A dopamine D2 receptor gene polymorphism and physical activity in two family studies
Simonen, R. L., Rankinen, T., Përusse, L., Leon, A. S., Skinner, J. S., Wilmore, J. H., Rao, D. C., & Bouchard, C. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00084-2 · Cited by 132
Blum, K., Noble, E. P., Sheridan, P. J., Montgomery, A., Ritchie, T., Ozkaragoz, T., Fitch, R. J., Wood, R., Finley, O., & Sadlack, F. (1993) · Alcohol · doi:10.1016/0741-8329(93)90054-r · Cited by 123
Hyperthermia in Psychostimulant Overdose
Callaway, C. W., & Clark, R. F. (1994) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(94)70165-2 · Cited by 124
Bodnar, R. J., Glass, M. J., Ragnauth, A. K., & Cooper, M. L. (1995) · Brain Research · doi:10.1016/0006-8993(95)00957-r · Cited by 138
Tsukada, H., Nishiyama, S., Kakiuchi, T., Ohba, H., Sato, K., Harada, N., & Nakanishi, S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02018-1 · Cited by 124
Withers, N. W., Pulvirenti, L., Koob, G. F., & Gillin, J. C. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199502000-00010 · Cited by 124
Self-citationZangen, A., Overstreet, D. H., & Yadid, G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01214-7 · Cited by 123
Guitart, X., Kogan, J. H., Berhow, M. T., Terwilliger, R. Z., Aghajanian, G. K., & Nestler, E. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91770-s · Cited by 126
Pulvirenti, L., Maldonado, R. J., & Koob, G. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)91145-5 · Cited by 128
Self-citationNeurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 121
Huntley, G. W., & Benson, D. L. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990517)407:4<453::aid-cne1>3.0.co;2-4 · Cited by 91
Hester, R., Simões‐Franklin, C., & Garavan, H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301326 · Cited by 134
Chronic cocaine‐mediated changes in non‐human primate nucleus accumbens gene expression
Freeman, W. M., Nader, M. A., Nader, S. H., Robertson, D. J., Gioia, L., Mitchell, S. M., Daunais, J. B., Porrino, L. J., Friedman, D. P., & Vrana, K. E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00252.x · Cited by 122
Arinami, T., Itokawa, M., Komiyama, T., Mitsushio, H., Mori, H., Mifune, H., Hamaguchi, H., & Toru, M. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90309-2 · Cited by 126
Ethanol and negative feedback regulation of mesolimbic dopamine release in rats
Kohl, R. R., Katner, J., Chernet, E., & McBride, W. J. (1998) · Psychopharmacology · doi:10.1007/s002130050692 · Cited by 132
Functional significance of mesolimbic dopamine
Kiyatkin, E. A. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00029-1 · Cited by 131
GABA Antagonist and Benzodiazepine Partial Inverse Agonist Reduce Motivated Responding for Ethanol
Rassnick, S., D'Amico, E., Riley, E., & Koob, G. F. (1993) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1993.tb00736.x · Cited by 122
Self-citationCocaine uptake is decreased in the brain of detoxified cocaine abusers
Volkow, N. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00073-m · Cited by 120
Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys
Lyons, D., Friedman, D., Nader, M., & Porrino, L. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01230.1996 · Cited by 120
Bontempi, B., & Sharp, F. R. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08596.1997 · Cited by 120
Cabib, S., & Puglisi-Allegra, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03333.1994 · Cited by 120
Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release
Campbell, A. D., Kohl, R. R., & McBride, W. J. (1996) · Alcohol · doi:10.1016/s0741-8329(96)00069-9 · Cited by 139
Xie, T., McCann, U. D., Kim, S., Yuan, J., & Ricaurte, G. A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07838.2000 · Cited by 120
Cocaine decreases self-control in rats: a preliminary report
Logue, A. W., Tobin, H., Chelonis, J. J., Wang, R. Y., Geary, N., & Schachter, S. (1992) · Psychopharmacology · doi:10.1007/bf02245509 · Cited by 127
Maldonado-Irizarry, C. S., & Kelley, A. E. (1994) · Psychopharmacology · doi:10.1007/bf02244872 · Cited by 132
Aracil-Fernández, A., Trigo, J. M., García‐Gutiérrez, M. S., Ortega-Álvaro, A., Ternianov, A., Navarro, D., Robledo, P., Berbel, P. J., Maldonado, R. J., & Manzanares, J. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.22 · Cited by 126
Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat
Yoshimoto, K., & McBride, W. J. (1992) · Neurochemical Research · doi:10.1007/bf00969884 · Cited by 118
Pleasure into pain: The consequences of long-term opioid use
White, J. M. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.007 · Cited by 127
Prazosin, an α-1 Adrenergic Antagonist, Reduces Cocaine-Induced Reinstatement of Drug-Seeking
Zhang, X. Y., & Kosten, T. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.003 · Cited by 124
Combined effects of systemic alcohol and nicotine on dopamine release in the nucleus accumbens shell
Tizabi, Y., Bai, L., Copeland, R. L., & Taylor, R. E. (2007) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm057 · Cited by 118
Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens
Miserendino, M. J. D., & Nestler, E. J. (1995) · Brain Research · doi:10.1016/0006-8993(95)00030-t · Cited by 118
Cummings, J. A., Jagannathan, L., Jackson, L. R., & Becker, J. B. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.09.009 · Cited by 117
Bassetti, C. L., Gugger, M., Bischof, M., Mathis, J., Sturzenegger, C., Werth, E., Radanov, B. P., Ripley, B. A., Nishino, S., & Mignot, E. J.-M. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(02)00191-0 · Cited by 127
Differences in response to an acoustic startle stimulus among forty-six rat strains
Glowa, J. R., & Hansen, C. T. (1994) · Behavior Genetics · doi:10.1007/bf01067931 · Cited by 125
Voltammetric study of the control of striatal dopamine release by glutamate
Borland, L. M., & Michael, A. C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02708.x · Cited by 115
Acute Opioid Receptor Desensitization And Tolerance: Is There A Link?
Borgland, S. L. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03418.x · Cited by 115
CNR1 Variation Modulates Risk for Drug and Alcohol Dependence
Zuo, L., Kranzler, H. R., Luο, X., Covault, J., & Gelernter, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.004 · Cited by 121
Attenuation of the Euphoric Effects of Cocaine by the Dopamine D1/D5 Antagonist Ecopipam (SCH 39166)
Romach, M. K., Glue, P., Kampman, K., Kaplan, H. L., Somer, G. R., Poole, S., Clarke, L., Coffin, V., Cornish, J., O'Brien, C. P., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1101 · Cited by 115
Hedonic homeostatic dysregulation as a driver of drug-seeking behavior
Koob, G. F. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2009.04.002 · Cited by 114
Self-citationBerton, F., Francesconi, W. G., Madamba, S. G., Zieglg??nsberger, W., & Siggins, G. R. (1998) · Alcoholism: Clinical & Experimental Research · doi:10.1097/00000374-199802000-00025 · Cited by 114
The neurovascular complications of cocaine
Fessler, R. D., Esshaki, C. M., Stankewitz, R. C., Johnson, R. R., & Diaz, F. G. (1997) · Surgical Neurology · doi:10.1016/s0090-3019(96)00431-4 · Cited by 113
Lamarque, S., Taghzouti, K., & Simon, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00039-9 · Cited by 133
Kiyatkin, E. A., Wise, R. A., & Gratton, A. (1993) · Synapse · doi:10.1002/syn.890140109 · Cited by 113
Bechara, A., Harrington, F., Nader, K., & Van der Kooy, D. (1992) · Behavioral Neuroscience · doi:10.1037/0735-7044.106.5.798 · Cited by 112
Increased Opioid Inhibition of GABA Release in Nucleus Accumbens during Morphine Withdrawal
Chieng, B., & Williams, J. T. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-17-07033.1998 · Cited by 112
Nirenberg, M. J., Chan, J., Vaughan, R. A., Uhl, G. R., Kuhar, M. J., & Pickel, V. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04037.1997 · Cited by 112
Rada, P. V., Mark, G. P., Pothos, E. N., & Hoebel, B. G. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90145-2 · Cited by 125
Mark, G. P., Hajnal, A. S., Kinney, A. E. “., & Keys, A. S. (1999) · Psychopharmacology · doi:10.1007/s002130050918 · Cited by 114
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.2.162 · Cited by 111
Jacobsen, L. K., Staley, J. K., Malison, R. T., Zoghbi, S. S., Seibyl, J. P., Kosten, T. R., & Innis, R. B. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.7.1134 · Cited by 110
The neurobiology of addiction: an overview.
Roberts, A. J., & Koob, G. F. (1997) · PubMed Central · Cited by 156
Self-citationAlcoholism: the role of different motivational systems.
Pihl, R. O., & Peterson, J. B. (1995) · PubMed · Cited by 128
Cocaine as a naturally occurring insecticide.
Nathanson, J. A., Hunnicutt, E. J., Kantham, L., & Scavone, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.20.9645 · Cited by 124
Pandey, S. C. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.002 · Cited by 122
THE GLYCINE REUPTAKE INHIBITOR ORG 25935 DECREASES ETHANOL INTAKE AND PREFERENCE IN MALE WISTAR RATS
Molander, A., Lidö, H. H., Löf, E., Ericson, M., & Söderpalm, B. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl085 · Cited by 124
Dahchour, A., Quertemont, É., & Witte, P. D. (1996) · Brain Research · doi:10.1016/0006-8993(96)00537-9 · Cited by 109
Green, E., Jacobson, A., Haase, L., & Murphy, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.071 · Cited by 108
Ponce, G., Jimenez-Arriero, M. A., Rubio, G., Hoenicka, J., Ampuero, I., Ramos, J. A., & Palomo, T. (2003) · European Psychiatry · doi:10.1016/j.eurpsy.2003.06.006 · Cited by 108
D3 Dopamine and Kappa Opioid Receptor Alterations in Human Brain of Cocaine‐overdose Victims
MASH, D. C., & STALEY, J. K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09286.x · Cited by 108
Oxytocin in learning and addiction: From early discoveries to the present
Sarnyai, Z., & Kovács, G. L. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.019 · Cited by 120
Laviolette, S. R., Nader, K., & van der Kooy, D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00327-8 · Cited by 117
Reinforcement processes in opiate addiction: A homeostatic model
Schulteis, G., & Koob, G. F. (1996) · Neurochemical Research · doi:10.1007/bf02532385 · Cited by 121
Self-citationPandey, S. C., Zhang, D., Mittal, N., & Nayyar, D. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38032-2 · Cited by 107
The "Ups and Downs" of Signaling Cascades in Addiction
Ron, D., & Jurd, R. (2005) · Science's STKE · doi:10.1126/stke.3092005re14 · Cited by 107
Inhibition by opioids of phagocytosis in peritoneal macrophages
Casellas, A. M., Guardiola, H., & Renaud, F. L. (1991) · Neuropeptides · doi:10.1016/0143-4179(91)90161-b · Cited by 107
Quinn, D. I., Wodak, A., & Day, R. O. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733050-00003 · Cited by 122
Molecular profiling of midbrain dopamine regions in cocaine overdose victims
Tang, W., Fasulo, W. H., Mash, D. C., & Hemby, S. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01740.x · Cited by 117
NEUROBIOLOGICAL CONSTRAINTS ON BEHAVIORAL MODELS OF MOTIVATION
Nader, K., Bechara, A., & van der Kooy, D. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.85 · Cited by 106
Gold-nanoparticle-based colorimetric array for detection of dopamine in urine and serum
Leng, Y., Xie, K., Ye, L., Li, G., Lu, Z., & He, J. (2015) · Talanta · doi:10.1016/j.talanta.2015.02.038 · Cited by 106
Rats orally self-administer corticosterone
Deroche‐Gamonet, V., Piazza, P. V., Deminière, J.-M., Moal, M. L., & Simon, H. (1993) · Brain Research · doi:10.1016/0006-8993(93)90837-d · Cited by 106
Individual differences in novelty-seeking behavior in rats: a c-fos study
Kabbaj, M., & Akil, H. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00291-3 · Cited by 113
Links Between Depression and Substance Abuse in Adolescents
Rao, U. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.07.002 · Cited by 122
Hemby, S. E., Co, C., Dworkin, S. I., & Smith, J. E. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37952-2 · Cited by 104
Metadata
- Authors
- Koob, G. F., & Bloom, F. E.
- Affiliations
- Scripps Clinic (US)
- ORCID
- Koob, George F.
- Venue
- Science
- Published
- 1988-11-04
- Volume
- 242
- Issue
- 4879
- Pages
- 715-723
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2061161259
- Semantic Scholar
- f6c96457aa8e089ddd837d35937c60d29361c45f
- Cited by
- 2,070
- References
- 189
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 15 · 2023: 19 · 2022: 24 · 2021: 25 · 2020: 30 · 2019: 40 · 2018: 32 · 2017: 24 · 2016: 35 · 2015: 39 · 2014: 47 · 2013: 51 · 2012: 56
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA-06420)
- National Institute on Drug Abuse (DA04043, DA04398)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug addiction, opiates, psychostimulants, ethanol, neurobiology of addiction, drug effects on behavior, long-term drug exposure
- MeSH terms
- Ethanol, Animals, Behavior, Animal, Brain, Cocaine, Drug Tolerance, Humans, Opium, Reinforcement, Psychology, Neurotransmitter Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.